Oviva is a Healthtech company based in Switzerland. It has raised $118M in total funding. Latest round: Series C.
Oviva funding overview
Oviva is a Healthtech company based in Switzerland. Oviva has raised $118M in total disclosed funding. That places its disclosed total in the $100M–$250M range. Its most recent disclosed round is a Series C announced in January 2021. The round record for Oviva runs through 2021; nothing later has been disclosed. Investors on record include AlbionVC, Eight Roads Ventures, F-Prime Capital, Partech, MTIP, Earlybird. 6 distinct backers are named across the disclosed rounds.
Oviva has raised $118M in total disclosed funding across the rounds on record.
Who has invested in Oviva?
AlbionVC, Eight Roads Ventures, F-Prime Capital, Partech, MTIP, Earlybird are named among the investors backing Oviva.
What was the latest Oviva funding round?
The most recent disclosed round is a Series C, announced in January 2021.
Where is Oviva based?
Oviva is based in Switzerland.
What sector does Oviva operate in?
Oviva is tracked under Healthtech from Switzerland, with $118M in disclosed funding.
When did Oviva last raise?
The last disclosed Oviva round closed in January 2021 at Series C.
Totals shown for Oviva aggregate every disclosed round on file. To see how that compares, browse the Healthtech companies in Switzerland and the investors behind them below.
